Literature DB >> 2651356

Two studies of the potential mechanisms of action in the thermal biofeedback treatment of vascular headache.

B Morrill, E B Blanchard.   

Abstract

Sixty vascular headache sufferers who underwent a standard protocol treatment of progressive relaxation and thermal biofeedback with autogenic training were studied for changes in hand temperature (the targeted response) and heart rate (a non-targeted response) to determine how such physiological change relates to reduction in headache activity. Overall, regardless of degree of improvement, subjects showed a significant, positive change over time in their ability to increase hand temperature. It was also found that inability to handwarm at session one of thermal biofeedback training was predictive of treatment success, as was the ability to achieve a fingertip temperature of at least 96.0 degrees F at any point in thermal biofeedback training. In addition, it was found that migraine headache sufferers who were treatment successes had significantly lowered their heart rates from pre- to post-treatment assessment.

Entities:  

Mesh:

Year:  1989        PMID: 2651356     DOI: 10.1111/j.1526-4610.1989.hed2903169.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

1.  Preliminary study: psychological effects of muscle relaxation on juvenile delinquents.

Authors:  Naoki Nakaya; Hiroaki Kumano; Keiji Minoda; Takashi Koguchi; Kozo Tanouchi; Motoyori Kanazawa; Shin Fukudo
Journal:  Int J Behav Med       Date:  2004

2.  The role of absorption capacity in thermal biofeedback treatment of vascular headache.

Authors:  B D Steffek; E B Blanchard
Journal:  Biofeedback Self Regul       Date:  1991-09

Review 3.  Is there a causal relationship between stress and migraine? Current evidence and implications for management.

Authors:  Anker Stubberud; Dawn C Buse; Espen Saxhaug Kristoffersen; Mattias Linde; Erling Tronvik
Journal:  J Headache Pain       Date:  2021-12-20       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.